Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Gliosarcoma × Ipilimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Melanoma 122 Carcinoma, Non-Small-Cell Lung 33 Carcinoma, Renal Cell 29 Neoplasm Metastasis 28 Prostatic Neoplasms 19 Brain Neoplasms 19 Pancreatic Neoplasms 16 Lung Neoplasms 16 Neoplasms 15 Uveal Melanoma 14 Breast Neoplasms 13 Sarcoma 12 Carcinoma, Hepatocellular 12 Skin Neoplasms 10 Kidney Neoplasms 10 Urinary Bladder Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Triple Negative Breast Neoplasms 7 Small Cell Lung Carcinoma 7 Ovarian Neoplasms 7 Glioblastoma 7 Colorectal Neoplasms 7 Colonic Neoplasms 7 Recurrence 6 Multiple Myeloma 6 Diabetes Mellitus, Insulin-Dependent, 12 6 Clear-cell metastatic renal cell carcinoma 6 Carcinoma, Transitional Cell 6 Uterine Cervical Neoplasms 5 Rectal Neoplasms 5

Interventions

Temozolomide 80 Radiotherapy 47 Bevacizumab 29 Irinotecan 18 Radiation 15 Erlotinib Hydrochloride 14 Carmustine 13 Magnetic Resonance Spectroscopy 12 O(6)-benzylguanine 10 Chemotherapy, Adjuvant 10 sargramostim 8 Thalidomide 8 Imatinib Mesylate 8 Carboplatin 8 Gene Expression Profiling 6 Filgrastim 6 Drug Therapy 6 Surgical Procedures, Operative 5 Radiotherapy, Intensity-Modulated 5 Hydroxyurea 5 Gefitinib 5 pembrolizumab 4 aldesleukin 4 Topotecan 4 Immunohistochemistry 4 Etoposide 4 Dasatinib 4 Celecoxib 4 Biopsy 4 Aminolevulinic Acid 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07134842 2025-08-21

WinGlio-ipi

University College, London

Phase 1 Recruiting

Brain Neoplasms, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡